91 related articles for article (PubMed ID: 33320964)
21. Implications of polygenic risk for personalised colorectal cancer screening.
Frampton MJ; Law P; Litchfield K; Morris EJ; Kerr D; Turnbull C; Tomlinson IP; Houlston RS
Ann Oncol; 2016 Mar; 27(3):429-34. PubMed ID: 26578737
[TBL] [Abstract][Full Text] [Related]
22. Impact of organised colorectal cancer screening on age-specific population incidences: evidence from a quasi-experimental study in Sweden.
Chauca Strand G; Strömberg U; Forsberg A; Bonander C
Eur J Epidemiol; 2024 Jan; 39(1):87-96. PubMed ID: 38177571
[TBL] [Abstract][Full Text] [Related]
23. Outcomes at follow-up of negative colonoscopy in average risk population: systematic review and meta-analysis.
Heisser T; Peng L; Weigl K; Hoffmeister M; Brenner H
BMJ; 2019 Nov; 367():l6109. PubMed ID: 31722884
[TBL] [Abstract][Full Text] [Related]
24. Data-Powered Participatory Decision Making: Leveraging Systems Thinking and Simulation to Guide Selection and Implementation of Evidence-Based Colorectal Cancer Screening Interventions.
Wheeler SB; Leeman J; Hassmiller Lich K; Tangka FKL; Davis MM; Richardson LC
Cancer J; 2018; 24(3):136-143. PubMed ID: 29794539
[TBL] [Abstract][Full Text] [Related]
25. Frequency of Screening for Colorectal Cancer by Predicted Life Expectancy Among Adults 76-85 Years.
Deardorff WJ; Lu K; Jing B; Jeon SY; Boscardin WJ; Fung KZ; Lee SJ
JAMA; 2023 Oct; 330(13):1280-1282. PubMed ID: 37676665
[TBL] [Abstract][Full Text] [Related]
26. Colorectal Cancer Screening Receipt Does Not Differ by 10-Year Mortality Risk Among Older Adults.
Liu PH; Singal AG; Murphy CC
Am J Gastroenterol; 2024 Feb; 119(2):353-363. PubMed ID: 37782288
[TBL] [Abstract][Full Text] [Related]
27. Colorectal screening guidelines in acromegaly.
Perry I; Stewart PM; Kane K
Gut; 2003 Sep; 52(9):1387; author reply 1387. PubMed ID: 12912882
[No Abstract] [Full Text] [Related]
28. NordICC Trial Results in Line With Expected Colorectal Cancer Mortality Reduction After Colonoscopy: A Modeling Study.
van den Berg DMN; Nascimento de Lima P; Knudsen AB; Rutter CM; Weinberg D; Lansdorp-Vogelaar I;
Gastroenterology; 2023 Oct; 165(4):1077-1079.e2. PubMed ID: 37454978
[No Abstract] [Full Text] [Related]
29. Understanding the Results of a Randomized Trial of Screening Colonoscopy.
Dominitz JA; Robertson DJ
N Engl J Med; 2022 Oct; 387(17):1609-1611. PubMed ID: 36214591
[No Abstract] [Full Text] [Related]
30. Engaging stakeholders in the use of an interactive simulation tool to support decision-making about the implementation of colorectal cancer screening interventions.
O'Leary MC; Hassmiller Lich K; Mayorga ME; Hicklin K; Davis MM; Brenner AT; Reuland DS; Birken SA; Wheeler SB
Cancer Causes Control; 2023 Dec; 34(Suppl 1):135-148. PubMed ID: 37147411
[TBL] [Abstract][Full Text] [Related]
31. Projected long-term effects of colorectal cancer screening disruptions following the COVID-19 pandemic.
Nascimento de Lima P; van den Puttelaar R; Hahn AI; Harlass M; Collier N; Ozik J; Zauber AG; Lansdorp-Vogelaar I; Rutter CM
Elife; 2023 May; 12():. PubMed ID: 37129468
[TBL] [Abstract][Full Text] [Related]
32. Should colorectal cancer screening start at the same age in European countries? Contributions from descriptive epidemiology.
Brenner H; Hoffmeister M; Haug U
Br J Cancer; 2008 Aug; 99(3):532-5. PubMed ID: 18628760
[TBL] [Abstract][Full Text] [Related]
33. The impact of colorectal cancer screening on the US population: is it time to celebrate?
Doubeni CA
Cancer; 2014 Sep; 120(18):2810-3. PubMed ID: 24895320
[No Abstract] [Full Text] [Related]
34. Modeling the prevention of colorectal cancer from the combined impact of host and behavioral risk factors.
Frampton M; Houlston RS
Genet Med; 2017 Mar; 19(3):314-321. PubMed ID: 27490113
[TBL] [Abstract][Full Text] [Related]
35. Screening For Colorectal Cancer in the Age of Simulation Models: A Historical Lens.
Phillips CJ; Schoen RE
Gastroenterology; 2020 Oct; 159(4):1201-1204. PubMed ID: 32682768
[No Abstract] [Full Text] [Related]
36. The value of explicitly emulating a target trial when using real world evidence: an application to colorectal cancer screening.
García-Albéniz X; Hsu J; Hernán MA
Eur J Epidemiol; 2017 Jun; 32(6):495-500. PubMed ID: 28748498
[TBL] [Abstract][Full Text] [Related]
37. Sequentially calibrating a Bayesian microsimulation model to incorporate new information and assumptions.
DeYoreo M; Rutter CM; Ozik J; Collier N
BMC Med Inform Decis Mak; 2022 Jan; 22(1):12. PubMed ID: 35022005
[TBL] [Abstract][Full Text] [Related]
38. Using computational modeling to assess the impact of clinical decision support on cancer screening improvement strategies within the community health centers.
Carney TJ; Morgan GP; Jones J; McDaniel AM; Weaver M; Weiner B; Haggstrom DA
J Biomed Inform; 2014 Oct; 51():200-9. PubMed ID: 24953241
[TBL] [Abstract][Full Text] [Related]
39. Correction: Development and validation of a simulation-based assessment tool in colonoscopy.
Jaensch C; Jensen RD; Paltved C; Madsen AH
Adv Simul (Lond); 2023 Dec; 8(1):32. PubMed ID: 38124212
[No Abstract] [Full Text] [Related]
40. Merits, Challenges, and Limitations of Randomized Trials on Colorectal Cancer Screening Effectiveness.
Brenner H; Cross AJ
Gastroenterology; 2021 Mar; 160(4):1009-1011. PubMed ID: 33359088
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
